Published 3 days ago • loading... • Updated 2 days ago

Target ALS Highlighted in New Case Study Released by Harvard Kennedy School Focused on Innovative Model for Collaborative Medical Research

On March 28, 2025, the Harvard Kennedy School will premiere a case study titled 'Dan Doctoroff and the Power of Collaboration' about the work of Target ALS.
Dan Doctoroff, a former Deputy Mayor and visionary leader diagnosed with ALS in 2021, founded Target ALS after losing his father and uncle to the disease, seeking a new approach to ALS research.
The case study, intended for graduate and executive education at Harvard's Kennedy and Business Schools, examines Target ALS's strategic leadership, cross-sector collaboration, and innovative funding models in driving transformative progress in medical research.
Manish Raisinghani, CEO of Target ALS, stated that Target ALS was built to break down silos and accelerate progress through collaboration, while Professor Bilmes, a former classmate, admired Dan's ability to tackle complex challenges with bold strategic thinking.
Target ALS, since 2013, has revolutionized the ALS research landscape by pioneering the Innovation Ecosystem to dismantle traditional barriers, ensure open access to critical research tools, and unite academia, industry, and investors, aiming to transform ALS into a manageable disease and build a world where Everyone Lives.

Insights by Ground AI

Does this summary seem wrong?